FDA approves first generic version of tamiflu

FDA approves first generic version of tamiflu

(HealthDay)—The first generic version of the flu medication Tamiflu has been approved by the U.S. Food and Drug Administration.

Tamiflu (oseltamivir phosphate) is used to treat patients 2 weeks of age and older who have had for no more than 48 hours. It's also used for the prevention of flu in patients 1 year of age and older. The FDA approved Tamiflu in 1999.

Oseltamivir phosphate does not take the place of seasonal flu vaccination, the FDA emphasized.

The agency also said oseltamivir phosphate does not treat or prevent illnesses caused by infections other than the , and does not prevent bacterial infections that may happen with the flu.

More information: More Information

Copyright © 2016 HealthDay. All rights reserved.

Citation: FDA approves first generic version of tamiflu (2016, August 8) retrieved 29 November 2023 from https://medicalxpress.com/news/2016-08-fda-version-tamiflu.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

FDA expands tamiflu use to treat babies under one year old


Feedback to editors